Prevalence and predictors of trimethoprim-sulfamethoxazole resistance among uropathogenic Escherichia coli isolates in Michigan

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Patricia D BrownB Foxman

Abstract

Resistance among uropathogenic Escherichia coli to trimethoprim-sulfamethoxazole (TMP-SMX) has increased. Risk factors for resistance and the impact on clinical failure have been poorly described. We performed a retrospective cohort study of women with acute uncomplicated cystitis seen at a university health center and at primary care clinics in southeastern Michigan from 1992 to 1999. The prevalence of TMP-SMX resistance increased from 8.1% to 15.8% (P=.01). Women who had taken TMP-SMX recently were >16 times as likely as women who had not taken antibiotics recently to be infected with an isolate resistant to this agent; those who had taken any other antibiotic were more than twice as likely to be infected with a resistant isolate. Women infected with a TMP-SMX-resistant isolate who were treated with TMP-SMX were >17 times as likely to have treatment failure. Recent antibiotic use is a risk factor for infection with a TMP-SMX-resistant isolate; patients who are infected with a TMP-SMX-resistant isolate and who are treated with this agent are at a higher risk for clinical failure.

References

Oct 28, 1993·The New England Journal of Medicine·W E Stamm, T M Hooton
Oct 6, 1997·Infectious Disease Clinics of North America·T M Hooton, W E Stamm
Feb 3, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·G WeberP Yagupsky
Mar 3, 1999·JAMA : the Journal of the American Medical Association·K GuptaW E Stamm
Jul 15, 1999·The Journal of Antimicrobial Chemotherapy·D T SteinkeP G Davey
Aug 10, 1999·APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica·A BaerheimS Hunskaar
Nov 26, 1999·Journal of General Internal Medicine·S W WrightM L Haynes
Dec 10, 1999·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·J W WarrenW E Stamm
Apr 4, 2000·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·F W Goldstein
Jul 25, 2000·American Journal of Epidemiology·B FoxmanC F Marrs
Aug 10, 2000·The Journal of Antimicrobial Chemotherapy·W GoettschA J de Neeling
Sep 2, 2000·The Journal of Antimicrobial Chemotherapy·K G Naber
Dec 19, 2000·Annals of Epidemiology·B FoxmanJ D Sobel
Jul 5, 2001·Journal of Clinical Epidemiology·B FoxmanJ D Sobel

❮ Previous
Next ❯

Citations

Sep 27, 2008·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Staffan MårildTorsten Sandberg
Jan 9, 2009·Biomedical Microdevices·M Dominika KulinskiCatherine M Klapperich
Mar 24, 2005·International Urology and Nephrology·Chesley L Richards
Oct 7, 2003·International Journal of Antimicrobial Agents·Thomas M Hooton
Jul 24, 2003·Annals of Epidemiology·Laura N McEwenBetsy Foxman
Aug 4, 2012·Journal of American College Health : J of ACH·Ronald P Olson, Karen Haith
Jan 11, 2003·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·James A KarlowskyDaniel F Sahm
Jun 30, 2007·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Christopher A CzajaWalter E Stamm
Sep 24, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·David A TalanUNKNOWN EMERGEncy ID NET Study Group
Sep 24, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ebbing Lautenbach
Apr 8, 2010·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·Hassib Narchi, Muhaned Al-Hamdani
Sep 29, 2006·The Pediatric Infectious Disease Journal·Robert Cohen
Dec 19, 2007·Antimicrobial Agents and Chemotherapy·Richard ColganKalpana Gupta
Jan 11, 2012·Antimicrobial Agents and Chemotherapy·Anna K StuckKathrin Mühlemann
Feb 27, 2003·Antimicrobial Agents and Chemotherapy·Demetra KavathaGeorge Koratzanis
Jul 17, 2007·Clinical Microbiology Reviews·John Turnidge, David L Paterson
Oct 27, 2004·Emerging Infectious Diseases·Laurence HuangJannik Helweg-Larsen
Jan 1, 2011·African Journal of Traditional, Complementary, and Alternative Medicines : AJTCAM·Yanqing TongShiming Zeng
Feb 5, 2011·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Kalpana GuptaUNKNOWN European Society for Microbiology and Infectious Diseases
Jul 1, 2005·Women's Health·Lindsay E Nicolle
Jul 1, 2006·Women's Health·Patricia D Brown
Mar 26, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anne Marie FranceBetsy Foxman
Aug 16, 2011·The American Journal of Geriatric Pharmacotherapy·S James Matthews, Jason W Lancaster
Aug 11, 2004·Mayo Clinic Proceedings·Loren G Miller, Angela W Tang
Aug 19, 2008·The Journal of Infection·Carlo GagliottiUNKNOWN Emilia-Romagna Antibiotic Resistance Study Group
May 20, 2008·Primary Care·Dimitri M Drekonja, James R Johnson
Jul 30, 2015·Journal of Medical Microbiology·David A BookstaverMiguel A Arroyo
May 24, 2006·Pediatric Clinics of North America·Steven L Chang, Linda D Shortliffe
Aug 20, 2004·Diabetic Medicine : a Journal of the British Diabetic Association·R MeilandA I M Hoepelman
Feb 4, 2005·The Journal of Pediatrics·Sandra R ArnoldElaine E L Wang
Jul 5, 2005·Urology·J Curtis Nickel, Timothy Moon
Nov 12, 2013·Journal of Medical Microbiology·David A BookstaverKaron B Mansell
Mar 10, 2015·International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases·Louie Mar GangcuangcoMediadora Saniel
May 13, 2003·Expert Opinion on Pharmacotherapy·Lindsay Nicolle
Jun 30, 2016·The Journal of Antimicrobial Chemotherapy·Teh Li ChinAlasdair MacGowan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Related Papers

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
K GuptaWalter E Stamm
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
Thomas M HootonLindsay E Nicolle
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
J W WarrenWalter E Stamm
© 2022 Meta ULC. All rights reserved